Citadel Advisors »

Aprea Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Aprea Therapeutics (APRE) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Aprea Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aprea Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aprea Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $44k 51k 0.85
2025-03-31 $61k 30k 2.04

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
Spdr Gold Tr Gold Shs Call Option (GLD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Advanced Micro Devices Call Option (AMD)

View all positions for Citadel Advisors

Top funds holding Aprea Therapeutics

AIGH Capital Management
Murchinson
Sphera Funds Management
Nantahala Capital Management
DRW Holdings
Vanguard Group
Citadel Advisors
Jane Street
Geode Capital Management
Bnp Paribas Arbitrage, Snc
LPL Financial
XTX Topco
HighTower Advisors
BlackRock
Tower Research Capital

View all funds holding Aprea Therapeutics